I don't know if BuildGoodThings participates on th
Post# of 157604

There is still a lot for we laypeople to grasp. However, between Dr. Jay's podcast and Mr. Hoffman's presentation the pieces are coming together. I also note that some excellent questions have been posed here subsequent to yesterday. It is past time for a shareholder's meeting so that these questions can be answered for present and future investors.
A number of us have tried to contact management through the Cytodyn website, but to no avail. The company's reluctance to respond is puzzling. If IR monitors activity here, I encourage you to indeed provide "investor relations".

